Farzan brings more than two decades’ leadership experience with a strong track record in fundraising and IPOs THOUSAND OAKS, Calif., July 22, 2024 /PRNewswire/ — Latigo Biotherapeutics Inc. (“Latigo”), a clinical-stage biotechnology company developing best-in-class non-opioid pain…
Month: July 2024
Farzan brings more than two decades’ leadership experience with a strong track record in fundraising and IPOs THOUSAND OAKS, Calif., July 22, 2024 /PRNewswire/ — Latigo Biotherapeutics Inc. (“Latigo”), a clinical-stage biotechnology company developing best-in-class non-opioid pain…
NEW YORK, July 22, 2024 /PRNewswire/ — Legacy, North America’s #1 digital fertility clinic for men, has released a new version of its groundbreaking at-home sperm testing and freezing kit. The kit’s enhanced features improve its accuracy, security and ease of use, taking Legacy’s…
NEW YORK, July 22, 2024 /PRNewswire/ — Legacy, North America’s #1 digital fertility clinic for men, has released a new version of its groundbreaking at-home sperm testing and freezing kit. The kit’s enhanced features improve its accuracy, security and ease of use, taking Legacy’s…
MCLEAN, Va., July 22, 2024 /PRNewswire/ — V2X, Inc. (NYSE:VVX) announces the award of a $48.5 million Indefinite Delivery Indefinite Quantity (IDIQ) contract by the U.S. Army, under the purview of the PEO Soldier portfolio, for the innovative Gateway Mission Router (GMR). The GMR creates…
MCLEAN, Va., July 22, 2024 /PRNewswire/ — V2X, Inc. (NYSE:VVX) announces the award of a $48.5 million Indefinite Delivery Indefinite Quantity (IDIQ) contract by the U.S. Army, under the purview of the PEO Soldier portfolio, for the innovative Gateway Mission Router (GMR). The GMR creates…
DUBLIN, July 22, 2024 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (“Jazz Pharmaceuticals”) today announced that it has completed a repricing of the approximately $2.7 billion outstanding balance of its U.S. dollar term loans under its credit facility. The applicable margin…
DUBLIN, July 22, 2024 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (“Jazz Pharmaceuticals”) today announced that it has completed a repricing of the approximately $2.7 billion outstanding balance of its U.S. dollar term loans under its credit facility. The applicable margin…
Lloyd’s, le premier acteur mondial de l’assurance, a donné son accord à MCI Syndicate 1966 pour offrir une assurance pour les essais cliniques, s’appuyant sur la plateforme MAT AI de GATC, afin de réduire considérablement le risque financier dans le développement de médicaments…
Lloyd’s, le premier acteur mondial de l’assurance, a donné son accord à MCI Syndicate 1966 pour offrir une assurance pour les essais cliniques, s’appuyant sur la plateforme MAT AI de GATC, afin de réduire considérablement le risque financier dans le développement de médicaments…